EUVIMEDEUVIMED entdecken
Crossref

System-level metabolic and enzyme engineering enables high-titer gastrodin biosynthesis in yeast

Xiaowen Wan, Donghao Li, Minghai Tang, Zewen Liu, Jiayu Pan, Hongbin Yu, Jinliang Yang, Huayi Liu

Bioresource Technology · 2026-08 · 454 · 134802

DOI: 10.1016/j.biortech.2026.134802 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioresource Technology, 2026-08. Verfasst von Xiaowen Wan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biotherapy and Cancer Centre/Collaborative Innovation Centre for Biotherapy, West China Hospital, Sichuan University, Chengdu…. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Benzyl Alcohols, Glucosides, Metabolic Engineering. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastrodin is a clinically used neuroprotective phenolic glycoside for the treatment of migraine and other neurovascular disorders, yet its sustainable and scalable production remains challenging. Microbial biosynthesis of gastrodin is intrinsically limited by restricted carbon flux into the shikimate pathway, strong metabolic competition at the chorismate node, and the low catalytic efficiency of plant-derived UDP-glycosyltransferases toward 4-hydroxybenzyl alcohol. In this work, a mechanism-guided metabolic and enzyme reprogramming strategy was established to overcomes these bottlenecks and enables industrial-level production of gastrodin in Saccharomyces cerevisiae. Carbon entry into the shikimate pathway was strengthened by engineering a strongly feedback-insensitive Aro3 variant, together with structure-guided attenuation of Aro7 that reduced l-phenylalanine and l-tyrosine formation while preserving essential physiological function. To sustain high-flux precursor generation, central carbon metabolism was systematically reconfigured by enhancing pentose phosphate pathway activity and tuning phosphoenolpyruvate-pyruvate partitioning, thereby elevating erythrose-4-phosphate, phosphoenolpyruvate, and NADPH availability. To resolve the terminal bottleneck, structure-guided evolution of AtUGT72B1 yielded a glycosyltransferase variant with a 26.6-fold increase in catalytic efficiency relative to the wild-type enzyme, while reinforcement of UDP-glucose biosynthesis further supported efficient glycosylation under elevated pathway flux. Integration of these multi-layered engineering strategies enabled production of 19.01 mM (5.44 g/L) gastrodin in shake flasks and 90.34 g/L in fed-batch fermentation, representing the highest microbial titer reported to date. Overall, this work demonstrates that synchronizing central metabolic architecture with tailored enzyme performance provides a generalizable framework for unlocking industrial-scale microbial biosynthesis of complex plant natural products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Saccharomyces cerevisiaeBenzyl AlcoholsGlucosidesMetabolic EngineeringProtein EngineeringShikimic AcidCarbonPentose Phosphate Pathway

Stichwörter der Autor:innen

Chorismate mutaseDAHP synthaseEnzyme engineeringGastrodinGlycosyltransferaseMetabolic engineering

Substanzen

Benzyl AlcoholsgastrodinGlucosidesShikimic AcidCarbon

Autor:innen und Institutionen

  • State Key Laboratory of Biotherapy and Cancer Centre/Collaborative Innovation Centre for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • State Key Laboratory of Biotherapy and Cancer Centre/Collaborative Innovation Centre for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China; Biology Engineering College, Key Laboratory of Biotech…
  • Department of Hematology, West China Hospital, Sichuan University, Chengdu 610041, China.
  • State Key Laboratory of Biotherapy and Cancer Centre/Collaborative Innovation Centre for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: jinliangyang@scu.edu.cn.
  • State Key Laboratory of Biotherapy and Cancer Centre/Collaborative Innovation Centre for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China; School of Life Science and Engineering, Southwest Jiao…

Förderung

  • National Natural Science Foundation of China
  • Sichuan Province Science and Technology Support Program

Zitieren

APA

Wan, X., Li, D., Tang, M., Liu, Z., Pan, J., Yu, H., Yang, J., & Liu, H. (2026). System-level metabolic and enzyme engineering enables high-titer gastrodin biosynthesis in yeast. Bioresource Technology, 454, 134802. https://doi.org/10.1016/j.biortech.2026.134802

Vancouver

Wan X, Li D, Tang M, Liu Z, Pan J, Yu H, et al. System-level metabolic and enzyme engineering enables high-titer gastrodin biosynthesis in yeast. Bioresource Technology. 2026;454:134802. doi:10.1016/j.biortech.2026.134802

BibTeX
@article{Wan2026,
  author = {Wan, Xiaowen and Li, Donghao and Tang, Minghai and Liu, Zewen and Pan, Jiayu and Yu, Hongbin and Yang, Jinliang and Liu, Huayi},
  title = {System-level metabolic and enzyme engineering enables high-titer gastrodin biosynthesis in yeast},
  journal = {Bioresource Technology},
  year = {2026},
  volume = {454},
  pages = {134802},
  doi = {10.1016/j.biortech.2026.134802}
}
Kostenlos starten →